BioPharma SHAKTI: How a ₹10,000-Crore Budget Push Could Reshape India’s Healthcare and Innovation Economy
The Union Budget has unveiled a major push for India’s biopharmaceutical sector through a new initiative called BioPharma SHAKTI, backed by an outlay of ₹10,000 crore over five years. The government wants to help India move beyond making low-cost generic medicines and become a global hub for advanced biological drugs and biosimilars. These are complex…